Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 13/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5945262 | 0.89 | CRHR1 (0.42) | CRHR1MAPTNPC1KDM4E | |
| SCHEMBL5475681 | 0.85 | CRHR1 (0.41) | CRHR1DPP4DPP8DPP9HSP90AA1 | |
| SCHEMBL5804461 | 0.85 | NPC1 (0.50) | CRHR1DPP4DPP8DPP9HSP90AA1 | |
| SCHEMBL5465128 | 0.78 | CRHR1 (0.52) | CRHR1 | |
| SCHEMBL5473168 | 0.77 | CRHR1 (0.45) | CRHR1 | |
| SCHEMBL5945263 | 0.73 | CRHR1 (0.42) | CRHR1MAPTKDM4E | |
| SCHEMBL5849690 | 0.73 | HSP90AA1 (0.42) | CRHR1DPP4DPP8DPP9HSP90AA1 | |
| SCHEMBL2255137 | 0.72 | CRHR1 (0.44) | CRHR1DPP4DPP8DPP9HSP90AA1 | |
| SCHEMBL5848602 | 0.72 | POLB (0.41) | CRHR1MAPTKMT2AKDM4ETDP1 | |
| SCHEMBL5788518 | 0.69 | DPP4 (0.48) | CRHR1DPP4DPP8DPP9HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070224636-A1 | Pyrrolo[1,2b]pyridazine compounds and their uses | PFIZER INC | 2007-09-27 | — | — | US | disclosed |
| US-20070224636-A1 | Pyrrolo[1,2b]pyridazine compounds and their uses | PFIZER INC | 2007-09-27 | — | — | US | disclosed |
| US-20070224636-A1 | Pyrrolo[1,2b]pyridazine compounds and their uses | PFIZER INC | 2007-09-27 | — | — | US | disclosed |
| US-7056920-B2 | Pyrrolo[1,2-B]pyridazine compounds and their uses | PFIZER INC (US) | 2006-06-06 | — | — | US | disclosed |
| EP-1613631-A1 | PYRROLO 1,2-B PYRIDAZINE COMPOUNDS AND THEIR USES | Pharmacia & Upjohn Company LLC (US) | 2006-01-11 | — | — | EP | disclosed |
| WO-2004087709-A1 | PYRROLO[1,2-B]PYRIDAZINE COMPOUNDS AND THEIR USES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-10-14 | — | — | WO | disclosed |
| US-20040204415-A1 | Pyrrolo[1,2-B]pyridazine compounds and their uses | PFIZER INC | 2004-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204415-A1 | Pyrrolo[1,2-B]pyridazine compounds and their uses | CRHR1, CRHR2, CRH | CRHR1 1/4885MAPT 3276/4885DPP4 1559/4885 |
| US-20070224636-A1 | Pyrrolo[1,2b]pyridazine compounds and their uses | CRHR1, CRHR2, CRH | CRHR1 1/4885MAPT 3246/4885DPP4 1272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.